These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 28295713)

  • 21. Methazolamide-induced Stevens-Johnson syndrome: a warning!
    Cotter JB
    Arch Ophthalmol; 1998 Jan; 116(1):117. PubMed ID: 9445224
    [No Abstract]   [Full Text] [Related]  

  • 22. Toxic epidermal necrolysis: the year in review.
    Lee HY; Chung WH
    Curr Opin Allergy Clin Immunol; 2013 Aug; 13(4):330-6. PubMed ID: 23799330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of drug causality in Stevens-Johnson syndrome/toxic epidermal necrolysis: Concordance between lymphocyte transformation test and ALDEN.
    Bellón T; Rodríguez-Martín S; Cabañas R; Ramírez E; Lerma V; González-Herrada C; González O; Sendagorta E; Fiandor A; de Abajo FJ;
    Allergy; 2020 Apr; 75(4):956-959. PubMed ID: 31557316
    [No Abstract]   [Full Text] [Related]  

  • 24. [Toxic epidermal necrolysis (syndrome Lyell) versus Stevens-Johnson syndrome].
    Jezierska-Krupa B; Hyla-Klekot L
    Pediatr Pol; 1996 Jul; 71(7):615-20. PubMed ID: 8803466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Stevens-Johnson syndrome and toxic epidermal necrolysis: retrospective study of 185 cases in Abidjan (Côte d'Ivoire)].
    Kourouma S; Sangaré A; Kaloga M; Kouassi I; Ecra E; Gbery I; Ahogo C; Kouassi A; Kassi K; Camara B
    Med Sante Trop; 2014; 24(1):94-8. PubMed ID: 24736218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-specific upregulation of CD137 on CD8+ T cells aids in the diagnosis of multiple antibiotic toxic epidermal necrolysis.
    Trubiano JA; Redwood A; Strautins K; Pavlos R; Woolnough E; Chang CC; Phillips E
    J Allergy Clin Immunol Pract; 2017; 5(3):823-826. PubMed ID: 27888029
    [No Abstract]   [Full Text] [Related]  

  • 27. Effectiveness, safety and tolerability of cyclosporine versus supportive treatment in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A record-based study.
    Mohanty S; Das A; Ghosh A; Sil A; Gharami RC; Bandyopadhyay D; Das NK
    Indian J Dermatol Venereol Leprol; 2017; 83(3):312-316. PubMed ID: 28366923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis.
    Cartotto R
    Clin Plast Surg; 2017 Jul; 44(3):583-595. PubMed ID: 28576247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs causing severe ocular surface involvements in Japanese patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Kaniwa N; Ueta M; Nakamura R; Okamoto-Uchida Y; Sugiyama E; Maekawa K; Takahashi Y; Furuya H; Yagami A; Matsukura S; Ikezawa Z; Matsunaga K; Sotozono C; Aihara M; Kinoshita S; Saito Y
    Allergol Int; 2015 Oct; 64(4):379-81. PubMed ID: 26433536
    [No Abstract]   [Full Text] [Related]  

  • 30. Reciprocal contribution of Th17 and regulatory T cells in severe drug allergy.
    Hashizume H; Fujiyama T; Tokura Y
    J Dermatol Sci; 2016 Feb; 81(2):131-4. PubMed ID: 26596217
    [No Abstract]   [Full Text] [Related]  

  • 31. Toxic epidermal necrolysis and Stevens-Johnson syndrome: things we should know!
    Kamolz LP; Spendel S; Prandl EC
    Crit Care Med; 2011 Jun; 39(6):1600-1. PubMed ID: 21610649
    [No Abstract]   [Full Text] [Related]  

  • 32. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Fujita Y; Yoshioka N; Abe R; Murata J; Hoshina D; Mae H; Shimizu H
    J Am Acad Dermatol; 2011 Jul; 65(1):65-8. PubMed ID: 21507517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Absence of toxic epidermal necrolysis recurrence with pembrolizumab re-challenge in a patient with a positive lymphocyte transformation test.
    Kawada M; Nobeyama Y; Goto Y; Nakama K; Yamazaki N; Asahina A
    J Dermatol; 2020 Dec; 47(12):e424-e425. PubMed ID: 32815211
    [No Abstract]   [Full Text] [Related]  

  • 35. Stevens-Johnson syndrome/toxic epidermal necrolysis associated with ecstasy exposure.
    Wetzel M; Surkhabi W; Jung JY
    Australas J Dermatol; 2020 Aug; 61(3):276-277. PubMed ID: 32109316
    [No Abstract]   [Full Text] [Related]  

  • 36. Stevens-Johnson syndrome/toxic epidermal necrolysis mouse model generated by using PBMCs and the skin of patients.
    Saito N; Yoshioka N; Abe R; Qiao H; Fujita Y; Hoshina D; Suto A; Kase S; Kitaichi N; Ozaki M; Shimizu H
    J Allergy Clin Immunol; 2013 Feb; 131(2):434-41.e1-9. PubMed ID: 23111236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Prendiville J
    Adv Dermatol; 2002; 18():151-73. PubMed ID: 12528405
    [No Abstract]   [Full Text] [Related]  

  • 38. [Erythema multiforme exudativum, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell's syndrome) and their interrelationship].
    Kalamkarian AA; Samsonov VA
    Vestn Dermatol Venerol; 1980 Mar; (3):36-42. PubMed ID: 6990649
    [No Abstract]   [Full Text] [Related]  

  • 39. UK guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016 (print summary - Full guidelines available at http://dx.doi.org/10.1016/j.bjps.2016.01.034).
    Creamer D; Walsh SA; Dziewulski P; Exton LS; Lee HY; Dart JKG; Setterfield J; Bunker CB; Ardern-Jones MR; Watson KMT; Wong GAE; Philippidou M; Vercueil A; Martin RV; Williams G; Shah M; Brown D; Williams P; Mohd Mustapa MF; Smith CH
    J Plast Reconstr Aesthet Surg; 2016 Jun; 69(6):736-741. PubMed ID: 27216885
    [No Abstract]   [Full Text] [Related]  

  • 40. Toxic epidermal necrolysis-like lupus erythematosus: a condition to exclude in all patients with possible Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Truong K; Goldinger S; Kim J; Smith A; Fernandez-Peñas P
    J Eur Acad Dermatol Venereol; 2022 Mar; 36(3):e218-e221. PubMed ID: 34661931
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.